Baseline imbalance in randomised controlled trialsBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7203.185 (Published 17 July 1999) Cite this as: BMJ 1999;319:185
- Chris Roberts, senior research fellowa,
- David J Torgerson, senior research fellowb
- a National Primary Care Research Development Centre, University of Manchester, Manchester M13 9PL
- b National Primary Care Research and Development Centre, Centre for Health Economics, University of York, York YO1 5DD
- Correspondence to: Dr Roberts
In a controlled trial randomisation ensures that allocation of patients to treatments is left purely to chance. The characteristics of patients that may influence outcome are distributed between treatment groups so that any difference in outcome can be assumed to be due to the intervention. However, imbalance between groups in baseline variables that may influence outcome (such as age or disease severity) can bias statistical tests, a property sometimes referred to as chance bias Observed differences in outcome between groups in a particular trial could by chance be due to characteristics of the patients, not treatments. Some protection against chance bias is given by stratified randomisation or minimisation and by adjusting in the statistical analysis for baseline variables.
In reporting clinical trials it is recommended that prognostic variables should be described for each treatment group.1 This may …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial